M. Abend,^1,* S.A. Amundson,² C. Badie,³ K. Brzoska,⁴ R. Kriehuber,⁵ J. Lacombe,⁶ M. Lopez-Riego,⁷ K. Lumniczky,⁸ D. Endesfelder,⁹ G. O'Brien,³ S. Doucha-Senf,¹ S.A. Ghandhi,² R. Hargitai,⁸ E. Kis,⁸ L. Lundholm,⁷ D. Oskamp,⁵ P. Ostheim,¹ S. Schüle,¹ D. Schwanke,¹ I. Shuryak,² C. Siebenwith,¹ M. Unverricht-Yeboah,⁵ A. Wojcik,⁷ J. Yang,⁶ F. Zenhausern,⁶ M. Port<sup>1

1</sup>Bundeswehr Institute of Radiobiology, Munich, Germany
²Columbia University Irving Medical Center, Center for Radiological Research, New York, New York
³UK Health Security Agency and Office for Health Improvement and Disparities, Centre for Radiation, Chemical and Environmental Hazards, Oxfordshire, England
⁴Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Warsaw, Poland
⁵Forschungszentrum Jülich, Department of Safety and Radiation Protection, Jülich, Germany
⁶University of Arizona, Center for Applied Nanobioscience & Medicine, Phoenix, Arizona
⁷Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
⁸Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
⁹Bundesamt für Strahlenschutz, BfS, Oberschleißheim, Germany

^*Corresponding author: Michael Abend, M.D., Bundeswehr Institute of Radiobiology affiliated to University Ulm, Neuherbergstr. 11, 80937 Munich, Germany; email: michaelabend@bundeswehr.org.